Letter to the Editor
Split Viewer
Blood Res 2013; 48(2):
Published online June 25, 2013
https://doi.org/10.5045/br.2013.48.2.152
© The Korean Society of Hematology
Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
Division of Hematology, Tor Vergata University, Sant'Eugenio Hospital, Rome, Italy.
Correspondence to : Pasquale Niscola. Division of Hematology, Tor Vergata University, Sant'Eugenio Hospital, Piazzale dell'Umanesimo 10, 00144, Rome, Italy. pniscola@gmail.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
REFERENCES
- Bursztyn, B, Douer, D, Ramot, B. Chronic myelomonocytic leukemia following refractory anemia with sideroblasts: report of two cases. Eur J Haematol, 1987;38;197-199.
- Hasegawa, Y, Sakai, N, Toyama, M, Ninomiya, H, Abe, T. Chronic myelomonocytic leukemia transformed from refractory anemia with ring sideroblasts with a rare abnormal chromosome, inv (12). Rinsho Ketsueki, 1990;31;75-79.
- D'Angelo, G. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease. Lab Hematol, 2005;11;171-173.
- Breccia, M, Cannella, L, Frustaci, A, Stefanizzi, C, D'Elia, GM, Alimena, G. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems. Leuk Lymphoma, 2008;49;1292-1296.
- Singh, ZN, Post, GR, Kiwan, E, Maddox, AM. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature. Clin Lymphoma Myeloma Leuk, 2011;11;293-297.
- Parikh, SA, Tefferi, A. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol, 2012;87;610-619.
- Fianchi, L, Criscuolo, M, Breccia, M, et al. High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study. Leuk Lymphoma, 2013;54;658-661.
- Onida, F, Kantarjian, HM, Smith, TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood, 2002;99;840-849.
- Lyons, RM, Cosgriff, TM, Modi, SS, et al. Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes. J Clin Oncol, 2009;27;1850-1856.
- Gelsi-Boyer, V, Cervera, N, Bertucci, F, et al. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts. Haematologica, 2013;98;576-583.
PDF
Standard view
Export citation
Share Article
Letter to the Editor
Blood Res 2013; 48(2): 152-153
Published online June 25, 2013 https://doi.org/10.5045/br.2013.48.2.152
Copyright © The Korean Society of Hematology.
Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
Pasquale Niscola*, Andrea Tendas, Laura Scaramucci, Marco Giovannini, Stefano Fratoni, and Paolo de Fabritiis
Division of Hematology, Tor Vergata University, Sant'Eugenio Hospital, Rome, Italy.
Correspondence to: Pasquale Niscola. Division of Hematology, Tor Vergata University, Sant'Eugenio Hospital, Piazzale dell'Umanesimo 10, 00144, Rome, Italy. pniscola@gmail.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
- Bursztyn, B, Douer, D, Ramot, B. Chronic myelomonocytic leukemia following refractory anemia with sideroblasts: report of two cases. Eur J Haematol, 1987;38;197-199.
- Hasegawa, Y, Sakai, N, Toyama, M, Ninomiya, H, Abe, T. Chronic myelomonocytic leukemia transformed from refractory anemia with ring sideroblasts with a rare abnormal chromosome, inv (12). Rinsho Ketsueki, 1990;31;75-79.
- D'Angelo, G. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease. Lab Hematol, 2005;11;171-173.
- Breccia, M, Cannella, L, Frustaci, A, Stefanizzi, C, D'Elia, GM, Alimena, G. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems. Leuk Lymphoma, 2008;49;1292-1296.
- Singh, ZN, Post, GR, Kiwan, E, Maddox, AM. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature. Clin Lymphoma Myeloma Leuk, 2011;11;293-297.
- Parikh, SA, Tefferi, A. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol, 2012;87;610-619.
- Fianchi, L, Criscuolo, M, Breccia, M, et al. High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study. Leuk Lymphoma, 2013;54;658-661.
- Onida, F, Kantarjian, HM, Smith, TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood, 2002;99;840-849.
- Lyons, RM, Cosgriff, TM, Modi, SS, et al. Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes. J Clin Oncol, 2009;27;1850-1856.
- Gelsi-Boyer, V, Cervera, N, Bertucci, F, et al. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts. Haematologica, 2013;98;576-583.
Previous Article
